Year: 2024
AS Elenger Grupp (Elenger Grupp), a wholly owned subsidiary of Aktsiaselts Infortar (Infortar) and the German energy group EWE AG have entered into an agreement on the 31st of October 2024, under which EWE AG will sell 100% of the shares of its wholly owned subsidiary EWE Polska sp. z o.o. (EWE Polska) which operates in Poland. EWE Polska has two wholly owned subsidiaries, EWE Energia sp. z o.o. and EWE Przesył sp. z o.o. .
Polish Competition Authority (Polish: Urząd Ochrony Konkurencji i Konsumentów) has granted a merger permit to complete the transaction and after fulfilment other preconditions, today Elenger Grupp acquired a 100% shareholding in EWE Polska.
The main terms of the transaction for the acquisition of 100% of EWE Polska shares by Elenger Grupp, including the purchase price, are set out in the stock exchange release by Infortar...
Rackspace Technology Signs UK Armed Forces Covenant, Reinforcing Commitment to Veterans and the UK Public Sector
Written by Customer Service on . Posted in Public Companies.
Pledge highlights Rackspace dedication to supporting those who serve or have served in the Armed Forces, and their families
LONDON, Dec. 19, 2024 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), a leading provider of end-to-end hybrid, multicloud and AI technology solutions, is proud to announce its formal commitment to the UK Armed Forces by signing the Armed Forces Covenant. This pledge highlights Rackspace Technology’s dedication to supporting those who serve or have served in the Armed Forces, and their families.
The Armed Forces Covenant ensures that those who serve or have served in the armed forces, and their families, are treated fairly. By signing this Covenant, Rackspace Technology pledges to uphold the key principles of the Covenant, supporting the employment of veterans, service spouses, and partners, and offering...
Eurobio Scientific: EB Development obtains a significant majority of the capital with 88.9% held at the end of the Reopened Offer to continue its development with NextStage AM and IK Partners
Written by Customer Service on . Posted in Public Companies.
Eurobio Scientific: EB Development obtains a significant majority of the capital with 88.9% held at the end of the Reopened Offer to continue its development with NextStage AM and IK Partners
Paris, 19 December 2024 – 10.30am
Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible) and EB Development announce the final outcome of the takeover bid initiated by EB Development (the “Offer“), based on the results published on 18 December by the Autorité des marchés financiers (AMF) at the end of the reopening period of the Offer (the “Reopened Offer“).
644,911 ordinary shares were tendered to the Reopened Offer, which closed on 17 December 2024. These are in addition to the 4,582,971 ordinary shares tendered to the Initial Offer, giving a total of 5,227,882 ordinary shares tendered to the Offer, enabling EB...
Share Buyback Transaction Details December 12 – December 18, 2024
Written by Customer Service on . Posted in Public Companies.
PRESS RELEASE
Share Buyback Transaction Details December 12 – December 18, 2024
Alphen aan den Rijn – December 19, 2024 – Wolters Kluwer (Euronext: WKL), a global leader in professional information, software solutions, and services, today reports that it has repurchased 116,200 of its own ordinary shares in the period from December 12, 2024, up to and including December 18, 2024, for €18.9 million and at an average share price of €162.95.
These repurchases are part of the share buyback program announced on February 21, 2024, under which we intend to repurchase shares for €1 billion during 2024.
The cumulative amounts repurchased in the year to date under this program are as follows:
Share Buyback 2024Period
Cumulative shares repurchased in period
Total consideration(€ million)
Average share...
Certa Therapeutics Expands GPR68 Platform through Acquisition of OccuRx
Written by Customer Service on . Posted in Mergers And Acquisitions.
Strengthened Pipeline Targets Multiple Fibrotic Diseases
MELBOURNE, Australia, Dec. 19, 2024 (GLOBE NEWSWIRE) — Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with fibrotic diseases, today announces the acquisition of OccuRx, a Melbourne-based biotechnology company with highly complementary assets, resources and expertise, and a shared focus on targeting GPR68, a master switch of fibrosis.
The acquisition combines the assets and capabilities of two companies founded by a leader in the GPR68 field, Professor Darren Kelly, consolidating a pipeline that now includes two Phase 2 and one Phase 1 clinical candidates. Building on Professor Kelly’s pioneering research into inhibitors of GPR68 and benefiting from years of further development within biotechnology and major pharma...
Prosafe SE: Operational update – November 2024
Written by Customer Service on . Posted in Public Companies.
19 December – Fleet utilisation for November 2024 was 57 per cent.
In November, all operating vessels – Safe Notos, Safe Eurus, Safe Zephyrus and Safe Concordia – achieved 100 per cent utilisation.
Safe Zephyrus extension into Q3 2027 expected with Petrobras.
Safe Caledonia has commenced reactivation activities in Scapa Flow, UK, and will mobilise to the Captain Field, UK, within June 2025.
Safe Boreas is laid up in Norway pending relocation in Q2 2025 for a contract in Australia commencing earliest October 2025. The reactivation process is ongoing.
Safe Scandinavia is laid up in Norway.
Prosafe is a leading owner and operator of semi-submersible accommodation vessels. The company is listed on the Oslo Stock Exchange with ticker code PRS. For more information, please refer to https://www.prosafe.com
For further information,...
Suspension of Listing
Written by Customer Service on . Posted in Public Companies.
Albion KAY VCT PLC (LEI: 213800DK8H27QY3J5R45) (Company)
Prior to a resolution to cancel the listing of the Company’s shares on the Official List of the Financial Conduct Authority, which will be put to the Company’s shareholders at a general meeting of the Company to be held on 19 December 2024, trading in the Company’s shares has now been suspended.
For further information, please contact:
Vikash Hansrani Operations Partner Albion Capital Group LLP Company Secretary
Telephone: 020 7601 1850
Suspension of Listing
Written by Customer Service on . Posted in Public Companies.
Albion Venture Capital Trust PLC (LEI: 213800JKELS32V2OK421) (Company)
Prior to a resolution to cancel the listing of the Company’s shares on the Official List of the Financial Conduct Authority, which will be put to the Company’s shareholders at a general meeting of the Company to be held on 19 December 2024, trading in the Company’s shares has now been suspended.
For further information, please contact:
Vikash Hansrani Operations Partner Albion Capital Group LLP Company Secretary
Telephone: 020 7601 1850
Suspension of Listing
Written by Customer Service on . Posted in Public Companies.
Albion Development VCT PLC (LEI: 213800FDDMBD9QLHLB38) (Company)
Prior to a resolution to cancel the listing of the Company’s shares on the Official List of the Financial Conduct Authority, which will be put to the Company’s shareholders at a general meeting of the Company to be held on 19 December 2024, trading in the Company’s shares has now been suspended.
For further information, please contact:
Vikash Hansrani Operations Partner Albion Capital Group LLP Company Secretary
Telephone: 020 7601 1850
Syensqo announces early redemption of USD Senior Notes due May 2025
Written by Customer Service on . Posted in Public Companies.
Syensqo announces early redemption of USD Senior Notes due May 2025
Brussels, Belgium – December 19, 2024 – 08:30 CETSyensqo SA has delivered a notice of early redemption in full to holders of the Cytec Industries Inc. US dollar 3.95% senior notes due May 1, 2025 with ISIN US232820AK60 / CUSIP 232820AK6 (the “Bonds”) for the outstanding principal amount of USD 163,495,000. The redemption will be implemented in accordance with the terms and conditions of the bonds.
The redemption date will be February 1, 2025. The redemption price is 100% of the principal amount of the notes to be redeemed on the redemption date, plus accrued and unpaid interest thereon to, but not including, the redemption date (being USD $1,614,513.13). The paying agent is The Bank of New York Mellon.
ContactsInvestors & Analystsinvestor.relations@syensqo.com ...
